Semaglutide Superior to Other GLP-1 Analogues as Add-On to Basal Insulin in T2D
Once-weekly semaglutide 1.0 mg was also equally effective at reducing systolic blood pressure compared with liraglutide 1.8 mg.
Compared with GLP-1 receptor agonists, the use of SGLT2 inhibitors is associated with an increased risk for diabetic ketoacidosis and lower limb amputation.
Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease (CVD), and mortality in the general population.
Female nurses who frequently work rotating night shifts and adhere to an unhealthy lifestyle are at significantly greater risk of developing type 2 diabetes.